The Scientist

» clinical trials

Most Recent

image: Beware of Striking Medical Studies

Beware of Striking Medical Studies

By | October 25, 2012

A large-scale statistical analysis shows that medical studies revealing “very large effects” seldom stand up when other researchers try to replicate them.


image: More Questions About IV Drug

More Questions About IV Drug

By | October 18, 2012

Another clinical trial raises concerns about the efficacy and safety of a common intravenous treatment for patients that have lost large amounts of blood.


image: Uncloaking Clinical Trials

Uncloaking Clinical Trials

By | October 17, 2012

Glaxo­SmithKline will share long-sought, raw trial data—but access will be tightly controlled.  


image: Cantley Changes Jobs

Cantley Changes Jobs

By | September 14, 2012

Renowned cancer researcher Lewis Cantley is leaving Harvard to lead a new cancer center at Weill Cornell Medical College and NewYork-Presbyterian Hospital.


image: Scientists

Scientists "Spin" Results

By | September 13, 2012

A new study of the scientific literature finds that researchers are guilty of overemphasizing the benefits of medical treatments.


image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.


image: FDA to Debate Starch Treatment

FDA to Debate Starch Treatment

By | August 31, 2012

The US Food and Drug Administration will consider whether or not to stop the use of intravenous starch solutions to replace lost blood.


image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

Popular Now

  1. Rethinking the Rise of Mammals
    Daily News Rethinking the Rise of Mammals

    Mammals diversified 30 million years later than previously estimated, according to a new analysis of an ancient fossil.

  2. Wiping Out Gut Bugs Stops Obesity
  3. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

  4. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

Life Technologies